Bridging the Gap Between Clinical Suspicion of Neuroendocrine Tumors and Diagnosis With PET/CT When Pathology Is Unavailable: Considerations on Guidelines and Real Access to State-of-the-Art Molecular Imaging

Clin Nucl Med. 2024 Mar 1;49(3):226-227. doi: 10.1097/RLU.0000000000005003. Epub 2023 Dec 22.
No abstract available

MeSH terms

  • Humans
  • Molecular Imaging
  • Neuroendocrine Tumors* / diagnostic imaging
  • Neuroendocrine Tumors* / pathology
  • Organometallic Compounds*
  • Positron Emission Tomography Computed Tomography
  • Positron-Emission Tomography
  • Tomography, X-Ray Computed

Substances

  • Organometallic Compounds